1.56 USD
+0.060.00%
2026-08-03
市值
$66.77M
市盈率
—
EPS
-2.00
股息率
—
52 周区间
1.20 – 3.56
成交量
184.30K
Beta
1.83
目标价
11.50
52W 低 1.2052W 高 3.56
价格走势
公司简介
Acrivon Therapeutics, Inc., a clinical-stage biopharmaceutical company, discovers and develops oncology medicines for patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its generative phosphoproteomics platform. The company operates Acrivon Predictive Precision Proteomics (AP3), a precision medicine platform that enables the creation of drug specific proprietary OncoSignature companion diagnostics that are used to identify the patients to benefit from its drug candidates. Its lead clinical candidate is AC...